Diaphragm dysfunction in heart failure is accompanied by increases in neutral sphingomyelinase activity and ceramide content
about
Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failureInsulin Signaling and Heart Failure.Diaphragm dysfunction caused by sphingomyelinase requires the p47(phox) subunit of NADPH oxidase.Diaphragm muscle weakness in mice is early-onset post-myocardial infarction and associated with elevated protein oxidationSphingomyelinase promotes oxidant production and skeletal muscle contractile dysfunction through activation of NADPH oxidase.NAD(P)H oxidase subunit p47phox is elevated, and p47phox knockout prevents diaphragm contractile dysfunction in heart failure.The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the ratPharmacological targeting of mitochondrial reactive oxygen species counteracts diaphragm weakness in chronic heart failure.Diaphragm Abnormalities in Patients with End-Stage Heart Failure: NADPH Oxidase Upregulation and Protein Oxidation.Characterization of reactive oxygen species in diaphragm.Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle.Changes in the Diaphragm Lipid Content after Administration of Streptozotocin and High-Fat Diet Regime.Effect of plasma free fatty acid supply on the rate of ceramide synthesis in different muscle types in the rat.Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology.Inhibition of ceramide de novo synthesis as a postischemic strategy to reduce myocardial reperfusion injury.Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: Rationale and Study Design of a Prospective Randomized Controlled Trial.Respiratory muscle training decreases diaphragm DNA damage in rats with heart failure.
P2860
Q26745026-1D806E6C-E895-40F7-BF87-C7B0DABF6260Q30377910-1946A62F-3560-4112-BA45-481A0BC43D61Q34651154-1184282A-9862-4C71-B7C3-E754B1184925Q34800528-76016E86-B79D-4C63-A625-4747EC35AEDDQ34991932-887457E2-E2C4-44DF-BBA7-C85B95B9E9B6Q36017764-4E4F073F-0776-419D-8E78-CE9BA2EDE302Q36036237-E94DEC6C-FBAF-49FE-84F0-5063BA1CC13DQ36775314-4D877DFF-EDE3-41C3-A5EE-21F4D81F215CQ37570581-5B58D19A-2142-41FD-B8FB-16F58ED839F3Q38261430-974DB79C-FC15-4275-8FBF-0192DEF1BCCFQ41474222-E1C69B41-4227-46A6-88B3-89E36399C1D8Q46242454-EF5B1A4F-B74F-493C-A344-86F4DEE0990DQ46437110-D57AAE81-E930-430D-80DF-87C7137D599BQ46576175-A2790124-E4FD-41E7-BD04-41AD35D4D54AQ46608425-02BD7DBD-4AA7-491C-9128-A218577C5B2CQ47684601-1BDC2340-D7A7-4137-BCBB-EB74765EEDF3Q47808041-87077DE1-13F2-48C2-B7AE-53B1EB7D6909
P2860
Diaphragm dysfunction in heart failure is accompanied by increases in neutral sphingomyelinase activity and ceramide content
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Diaphragm dysfunction in heart ...... activity and ceramide content
@ast
Diaphragm dysfunction in heart ...... activity and ceramide content
@en
type
label
Diaphragm dysfunction in heart ...... activity and ceramide content
@ast
Diaphragm dysfunction in heart ...... activity and ceramide content
@en
prefLabel
Diaphragm dysfunction in heart ...... activity and ceramide content
@ast
Diaphragm dysfunction in heart ...... activity and ceramide content
@en
P2093
P2860
P356
P1476
Diaphragm dysfunction in heart ...... activity and ceramide content
@en
P2093
Demetra D Christou
Gergana M Deevska
Hyacinth M Empinado
Leonardo F Ferreira
Mariana Nikolova-Karakashian
P2860
P304
P356
10.1002/EJHF.73
P50
P577
2014-03-04T00:00:00Z